MétaCan
Menu
Back to cohort

No Adverse Signals Observed After Exposure to Human Papillomavirus Type 6/11/16/18 Vaccine During Pregnancy

2014· article· en· W2329247525 on OpenAlexaboutno aff
Mary Ann Goss, Fabio Lievano, Margaret M. Seminack, Adrian Dana

Bibliographic record

VenueObstetrics and Gynecology · 2014
Typearticle
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicinePregnancyGenital wartsObstetricsConfidence intervalLive birthPediatricsGynecologyCervical cancerInternal medicineCancer

Abstract

fetched live from OpenAlex

INTRODUCTION: Human papillomavirus (HPV) 6/11/16/18 vaccine (qHPV vaccine) is a quadrivalent vaccine for the prevention of cervical, vulvar, and vaginal cancers; their respective precancers; and genital warts caused by these vaccine types. As of December 2012, more than 50 million doses of qHPV vaccine have been distributed in the United States where the majority of exposures occurred. Because the vaccine is recommended for women of childbearing age, Merck and Co, Inc established the Pregnancy Registry for qHPV vaccine in 2006. A 6-year summary of the safety profile of pregnancy exposures and outcomes to the qHPV vaccine is presented. METHODS: Enrollment criteria to the registry included an identifiable patient and health care provider from the United States, France, or Canada exposed within 1 month before the date of onset of the last menstrual period or at any time during pregnancy. Outcomes of interest were pregnancy outcomes and birth defects. Prospectively reported cases (reported before the outcome of the pregnancy was known) were used for rate calculations because retrospectively reported cases (reported after the outcome is known) are considered to be inherently biased toward abnormal outcomes. The Metro Atlanta Congenital Defects Program methodology is used to compare and define birth defects and estimate rates. RESULTS: For the 1,573 prospective reports with known natural pregnancy outcomes, 1,452 (92%) were live births. Of 1,460 neonates, 1,381 (95%) were born without birth defects. The prevalence of major birth defects was 2.5 per 100 live-born neonates (95% confidence interval [CI] 1.7–3.4) and compares favorably with the observed Metro Atlanta Congenital Defects Program rate of 2.67 per 100. The overall rate of spontaneous abortion was 6.7 per 100 outcomes (95% CI 5.5–8.2). There were 12 fetal deaths (0.8/100 outcomes, 95% CI 0.4–1.4) not clustered around a specific abnormality. CONCLUSION: This is likely the largest HPV vaccine pregnancy registry to date. Rates of spontaneous abortions and major birth defects were not greater than the Metro Atlanta Congenital Defects Program unexposed population rates. Analysis of 6 years of pregnancy registry data shows no adverse signals. The qHPV vaccine is not recommended for use in pregnant women.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.022
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.022
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.306
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueObstetrics and GynecologySame topicCervical Cancer and HPV ResearchFrench-language works237,207